{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-097018","form_type":"8-K","ticker":"GRML","cik":"0001907223","company_name":"Greenland Mines Ltd","filed_at":"2024-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.325450+00:00","generated_at":"2026-05-30T01:13:23.987871+00:00","sec_items":["1.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Klotho terminates licensing deal for gamma-melanocortin MC1R rights","bullets":["Mutual termination of Jan 28, 2023 licensing agreement with Teleost Biopharmaceuticals.","Licensed rights no longer core to Klotho's business and research plans.","No further obligations or liabilities between parties; confidentiality survives.","Agreement covered worldwide rights to develop gamma-melanocortin drugs targeting MC1R receptors."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-097018","json":"https://secwatch.observer/filing/0001213900-24-097018.json","markdown":"https://secwatch.observer/filing/0001213900-24-097018.md","text":"https://secwatch.observer/filing/0001213900-24-097018.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1907223/000121390024097018/0001213900-24-097018-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1907223/000121390024097018/ea0220976-8k_klotho.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T01:13:23.987871+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}